Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other Non-Current Liabilities: 2009-2010

Historic Other Non-Current Liabilities for Madrigal Pharmaceuticals (MDGL) over the last 2 years, with Dec 2010 value amounting to $13.9 million.

  • Madrigal Pharmaceuticals' Other Non-Current Liabilities rose 104.56% to $12.5 million in Q1 2011 from the same period last year, while for Mar 2011 it was $12.5 million, marking a year-over-year increase of 104.56%. This contributed to the annual value of $13.9 million for FY2010, which is 83.96% up from last year.
  • As of FY2010, Madrigal Pharmaceuticals' Other Non-Current Liabilities stood at $13.9 million, which was up 83.96% from $7.5 million recorded in FY2009.
  • In the past 5 years, Madrigal Pharmaceuticals' Other Non-Current Liabilities ranged from a high of $13.9 million in FY2010 and a low of $7.5 million during FY2009.
  • Moreover, its 2-year median value for Other Non-Current Liabilities was $10.7 million (2009), whereas its average is $10.7 million.
  • Data for Madrigal Pharmaceuticals' Other Non-Current Liabilities shows a peak YoY spiked of 83.96% (in 2010) over the last 5 years.
  • Madrigal Pharmaceuticals' Other Non-Current Liabilities (Yearly) stood at $7.5 million in 2009, then spiked by 83.96% to $13.9 million in 2010.